Cargando…

Evaluation of Amebicidal and Cysticidal Activities of Antifungal Drug Isavuconazonium Sulfate against Acanthamoeba T4 Strains

Acanthamoeba species of amebae are often associated with Acanthamoeba keratitis, a severe corneal infection. Isavuconazonium sulfate is an FDA-approved drug for the treatment of invasive aspergillosis and mucormycosis. This prodrug is metabolized into the active isavuconazole moiety. Isavuconazole w...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shing, Brian, Balen, Mina, Debnath, Anjan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8707217/ https://www.ncbi.nlm.nih.gov/pubmed/34959694 http://dx.doi.org/10.3390/ph14121294

Ejemplares similares

Development of a Machine Learning-Based Cysticidal Assay and Identification of an Amebicidal and Cysticidal Marine Microbial Metabolite against Acanthamoeba
por: Shing, Brian, et al.
Publicado: (2022)

Amebicidal effects of fenugreek (Trigonella foenum‐graecum) against Acanthamoeba cysts
por: Kaya, Yasemin, et al.
Publicado: (2019)

In Vitro Comparison of the Acanthamoeba Cysticidal Activity of Povidone Iodine, Natamycin, and Chlorhexidine
por: Redd, Travis K., et al.
Publicado: (2021)

In Vitro Effect of Pitavastatin and Its Synergistic Activity with Isavuconazole against Acanthamoeba castellanii
por: Hahn, Hye Jee, et al.
Publicado: (2020)

Furanocoumarins from Ruta chalepensis with Amebicide Activity
por: Bazaldúa-Rodríguez, Aldo Fabio, et al.
Publicado: (2021)

The Role of Isavuconazonium Sulphate for the Treatment of Blastomycosis: A Case Series and Antifungal Susceptibility
por: Scolarici, Michael J, et al.
Publicado: (2022)

Subarachnoidal Neurocysticercosis non-responsive to cysticidal drugs: a case series
por: Cárdenas, Graciela, et al.
Publicado: (2010)

Safety, Tolerability, and Population Pharmacokinetics of Intravenous and Oral Isavuconazonium Sulfate in Pediatric Patients
por: Arrieta, Antonio C., et al.
Publicado: (2021)

1699. Safety and Outcomes of Isavuconazonium Sulfate for the Treatment of Invasive Aspergillosis or Invasive Mucormycosis in Pediatric Patients
por: Arrieta, Antonio C, et al.
Publicado: (2023)

1585. Isavuconazonium Sulfate plus Micafungin Improves Survival in an Immunocompromised Murine Model of Disseminated Fusariosis
por: Mavridou, Eleftheria, et al.
Publicado: (2019)

Pharmacokinetics, Safety, and Tolerability of Single and Multiple Doses of Isavuconazonium Sulfate in Healthy Adult Japanese Subjects
por: Shirae, Shinichiro, et al.
Publicado: (2022)

Tissue Distribution and Elimination of Isavuconazole following Single and Repeat Oral-Dose Administration of Isavuconazonium Sulfate to Rats
por: Schmitt-Hoffmann, Anne-Hortense, et al.
Publicado: (2017)

Comparative evaluation of isavuconazonium sulfate, voriconazole, and posaconazole for the management of invasive fungal infections in an academic medical center
por: Van Matre, Edward T., et al.
Publicado: (2019)

Pediatric Neurocysticercosis: Usefulness of Antibody Response in Cysticidal Treatment Follow-Up
por: Atluri, Venkata Subba Rao, et al.
Publicado: (2014)

742. Breakthrough Invasive Fungal Infections with Isavuconazonium Sulfate versus Voriconazole as Primary Antifungal Prophylaxis in Patients with Acute Myeloid Leukemia (AML) who Received Induction Chemotherapy
por: Singam, Hareesh v, et al.
Publicado: (2020)

1023. Isavuconazonium Use at an Academic Transplant Center
por: Servais, Abigail, et al.
Publicado: (2019)

1320. Pharmacokinetics of Isavuconazole Administered as Isavuconazonium Sulfate Intravenous Solution via Nasogastric Tube or Orally in Healthy Volunteers
por: Desai, Amit, et al.
Publicado: (2020)

Pharmacokinetics and Bioequivalence of Isavuconazole Administered as Isavuconazonium Sulfate Intravenous Solution via Nasogastric Tube or Orally in Healthy Subjects
por: Desai, Amit, et al.
Publicado: (2021)

A Pharmacokinetic Bioequivalence Study Comparing Different‐Strength and ‐Size Capsules of Isavuconazonium Sulfate in Healthy Japanese Subjects
por: Shirae, Shinichiro, et al.
Publicado: (2022)

1396. Predictions of Isavuconazonium Sulfate Dosage in Patients Aged 6 Months: <18 Years by Physiologically Based Pharmacokinetic Modeling
por: Desai, Amit, et al.
Publicado: (2018)

Prevalence, Response to Cysticidal Therapy, and Risk Factors for Persistent Seizure in Indian Children with Neurocysticercosis
por: Kumar, Animesh, et al.
Publicado: (2017)

Isavuconazonium for the treatment of Purpureocillium lilacinum infection in a patient with pyoderma gangrenosum
por: Accetta, Julia, et al.
Publicado: (2020)

2122. Isavuconazonium for Invasive Fungal Therapy: Single-Center Pediatric Experience
por: Mongkolrattanothai, Kanokporn, et al.
Publicado: (2019)

Isavuconazonium/pneumococcal vaccine: Vaccine failure and other toxicities: case report
Publicado: (2022)

Androgens Exert a Cysticidal Effect upon Taenia crassiceps by Disrupting Flame Cell Morphology and Function
por: Ambrosio, Javier R., et al.
Publicado: (2015)

Two Phase 1, Open‐Label, Mass Balance Studies to Determine the Pharmacokinetics of (14)C‐Labeled Isavuconazonium Sulfate in Healthy Male Volunteers
por: Townsend, Robert, et al.
Publicado: (2017)

β-cyclodextrin dendritic derivatives as permeation mediators to enhance the in vitro albendazole cysticidal activity by the improvement of the diffusion component
por: López-Méndez, Luis José, et al.
Publicado: (2022)

Modulation of Zinc Homeostasis in Acanthamoeba castellanii as a Possible Antifungal Strategy against Cryptococcus gattii
por: Ribeiro, Nicole S., et al.
Publicado: (2017)

Genotypic diversity of Acanthamoeba strains isolated from Chilean patients with Acanthamoeba keratitis
por: Jercic, María Isabel, et al.
Publicado: (2019)

In Vitro Evaluation of Combined Commercialized Ophthalmic Solutions Against Acanthamoeba Strains
por: Reyes-Batlle, María, et al.
Publicado: (2019)

Drug Discovery against Acanthamoeba Infections: Present Knowledge and Unmet Needs
por: Elsheikha, Hany M., et al.
Publicado: (2020)

Photochemotherapeutic strategies against Acanthamoeba keratitis
por: Siddiqui, Ruqaiyyah, et al.
Publicado: (2012)

The Activity of Polyhomoarginine against Acanthamoeba castellanii
por: Peguda, Hari Kumar, et al.
Publicado: (2022)

In-vitro Activity of Trigonella foenum graecum Seeds Against a Clinical Strain of Acanthamoeba Genotype T4
por: Dodangeh, Samira, et al.
Publicado: (2018)

Identification of plicamycin, TG02, panobinostat, lestaurtinib, and GDC-0084 as promising compounds for the treatment of central nervous system infections caused by the free-living amebae Naegleria, Acanthamoeba and Balamuthia
por: Kangussu-Marcolino, Monica M., et al.
Publicado: (2019)

406. Achievement of Clinical Isavuconazole (ISA) Serum and Plasma Drug Concentrations in Two Patients With Isavuconazonium Capsules Administered via Nasogastric Feeding Tube (NGT)
por: McCreary, Erin K, et al.
Publicado: (2018)

Detection of Acanthamoeba from Acanthamoeba Keratitis Mouse Model Using Acanthamoeba-Specific Antibodies
por: Kim, Min-Jeong, et al.
Publicado: (2022)

Assessing the Bioactive Profile of Antifungal-Loaded Calcium Sulfate against Fungal Biofilms
por: Butcher, Mark C., et al.
Publicado: (2021)

Galactose as novel target against Acanthamoeba cysts
por: Anwar, Ayaz, et al.
Publicado: (2019)

Amoebicidal activity of cationic carbosilane dendrons derived with 4-phenylbutyric acid against Acanthamoeba griffini and Acanthamoeba polyphaga trophozoites and cysts
por: López-Barona, P., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_u2jq1h5g46om3dqk5l6g44acrq